Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located

被引:38
作者
Zhao, Lujun
Chen, Ming
Ten Haken, Randall
Chetty, Indrin
Chapet, Olivier
Hayman, James A.
Kong, Feng-Ming
机构
[1] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[2] Vet Adm Hlth Ctr, Ann Arbor, MI USA
关键词
NSCLC; 3D conformal radiation therapy; node-negative disease; incidental nodal irradiation; dismetric analysis;
D O I
10.1016/j.radonc.2007.01.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: To determine the dose to regional nodal stations in patients with T1-3N0M0 non-small cell lung cancer (NSCLC) treated with three-dimensional conformal radiation therapy (3DCRT) without intentional elective nodal irradiation (ENI). Materials and methods: Twenty-three patients with medically inoperable T1-3N0M0 NSCLC were treated with 3DCRT without ENI. Hilar and mediastinal nodal regions were contoured on planning CT. The prescription dose was normalized to 70 Gy. Equivalent uniform dose (EUD) and other dosimetric parameters (e.g., V-40) were calculated for each nodal station. Results: The median EUD for the whole group ranged from 0.4 to 4.4 Gy for all elective nodal regions. Gross tumor volume (GTV) and the relationship between GTV and hilum were significantly correlated with irradiation dose to ipsilateral hilar nodal regions (P <.05). For patients with GTV >= 30.2 cm(3) (diameter approximate to 4 cm) and or having any overlap with hilum, the median EUDs were 9.6, 22.6, and 62.9 Gy for ipsilateral lower paratracheal, subcarinal, and ipsilateral hilar regions, respectively. The corresponding median V40 were 32.5%, 39.3%, and 97.6%, respectively. Conclusions: Although incidental nodal irradiation dose is low in the whole group, the dose to high-risk nodal regions is considerable in patients with T1-3N0 NSCLC when the primary is large and/or centrally located. Published by Elsevier Ireland Ltd.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 28 条
[1]   Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma [J].
Bradley, J ;
Graham, MV ;
Winter, K ;
Purdy, JA ;
Komaki, R ;
Roa, WH ;
Ryu, JK ;
Bosch, W ;
Emami, B .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (02) :318-328
[2]   Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields [J].
Bradley, JD ;
Wahab, S ;
Lockett, MA ;
Perez, CA ;
Purdy, JA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (02) :342-347
[3]   Re-examining the role of elective nodal irradiation - Finding ways to maximize the therapeutic ratio [J].
Chang, DT ;
Zlotecki, RA ;
Olivier, KR .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06) :597-602
[4]   CT-based definition of thoracic lymph node stations: An atlas from the University of Michigan [J].
Chapet, O ;
Kong, FM ;
Quint, LE ;
Chang, AC ;
Ten Haken, RK ;
Eisbruch, A ;
Hayman, JA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (01) :170-178
[5]   Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: Is low incidence of regional failure due to incidental nodal irradiation? [J].
Chen, M ;
Hayman, JA ;
Ten Haken, RK ;
Tatro, D ;
Fernando, S ;
Kong, FM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (01) :120-126
[6]   Involved-field radiotherapy alone for early-stage non-small-cell lung cancer [J].
Cheung, PCF ;
Mackillop, WJ ;
Dixon, P ;
Brundage, MD ;
Youssef, YM ;
Zhou, S .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (03) :703-710
[7]   Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer? [J].
Doddoli, C ;
Aragon, A ;
Barlesi, F ;
Chetaille, B ;
Robitail, S ;
Giudicelli, R ;
Fuentes, P ;
Thomas, P .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2005, 27 (04) :680-685
[8]   Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer [J].
Hayakawa, K ;
Mitsuhashi, N ;
Saito, Y ;
Nakayama, Y ;
Furuta, M ;
Sakurai, H ;
Kawashima, M ;
Ohno, T ;
Nasu, S ;
Niibe, H .
LUNG CANCER, 1999, 26 (03) :137-142
[9]   RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER [J].
HOLMES, CE ;
RUCKDESCHEL, JC ;
JOHNSTON, M ;
THOMAS, PA ;
DESLAURIERS, J ;
GROVER, FL ;
HILL, LD ;
FELD, R ;
GINSBERG, RJ ;
MOUNTAIN, CF ;
DZUIBAN, S ;
KIELY, M ;
MCKNEALLY, MF ;
MOORES, DWO ;
RAMNES, C ;
WAGNER, H ;
BUNN, P ;
CHU, H ;
DIENHART, D ;
HAZUKA, M ;
KINZIE, J ;
SORENSEN, J ;
VANCE, V ;
BRAUN, T ;
HOPEMAN, A ;
KANE, M ;
RUSS, P ;
WHITMAN, GJR ;
FALL, SM ;
HANSEN, DP ;
HENDERSON, RH ;
MONCRIEF, CL ;
PAULING, F ;
SIMS, J ;
TELL, D ;
WISELYCARR, S ;
ABERNATHY, CM ;
CLARK, DA ;
MCCROSKEY, B ;
MOORE, G ;
MOORE, F ;
MYERS, A ;
WHITE, M ;
BROOKS, RJ ;
BULL, M ;
JOHNSON, FB ;
NEIMYR, M ;
PAQUETTE, FR ;
SACCOMANNO, G ;
LAD, T .
ANNALS OF THORACIC SURGERY, 1995, 60 (03) :615-622
[10]   STRATEGY FOR LYMPHADENECTOMY IN LUNG-CANCER 3 CENTIMETERS OR LESS IN DIAMETER [J].
ISHIDA, T ;
YANO, T ;
MAEDA, K ;
KANEKO, S ;
TATEISHI, M ;
SUGIMACHI, K .
ANNALS OF THORACIC SURGERY, 1990, 50 (05) :708-713